158 related articles for article (PubMed ID: 28044374)
1. Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review.
Neves Filho EH; de Sant'Ana RO; Nunes LV; Pires AP; da Cunha MD
APMIS; 2017 Feb; 125(2):79-84. PubMed ID: 28044374
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
[TBL] [Abstract][Full Text] [Related]
3. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
4. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma.
Derieux S; Svrcek M; Manela S; Lagorce-Pages C; Berger A; André T; Taieb J; Paye F; Voron T
Dig Liver Dis; 2020 Jan; 52(1):107-114. PubMed ID: 31427088
[TBL] [Abstract][Full Text] [Related]
6. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.
Langer R; Becker K
Virchows Arch; 2018 Feb; 472(2):175-186. PubMed ID: 28918544
[TBL] [Abstract][Full Text] [Related]
7. The association among HER2, MET and FOXP3 expression and tumor regression grading in gastric adenocarcinoma.
Neves Filho EHC; Pires APB; de Sant'Ana RO; Rabenhorst SHB; Hirth CG; da Cunha MDPSS
APMIS; 2018 May; 126(5):389-395. PubMed ID: 29696715
[TBL] [Abstract][Full Text] [Related]
8. Connection and distinction of tumor regression grading systems of gastrointestinal cancer.
Tong Y; Liu D; Zhang J
Pathol Res Pract; 2020 Sep; 216(9):153073. PubMed ID: 32825946
[TBL] [Abstract][Full Text] [Related]
9. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
Saliba G; Detlefsen S; Carneiro F; Conner J; Dorer R; Fléjou JF; Hahn H; Kamaradova K; Mastracci L; Meijer SL; Sabo E; Sheahan K; Riddell R; Wang N; Yantiss RK; Lundell L; Low D; Vieth M; Klevebro F
Hum Pathol; 2021 Feb; 108():60-67. PubMed ID: 33221343
[TBL] [Abstract][Full Text] [Related]
10. [Pathological evaluation system for preoperative treatment of gastric cancer].
Ma Q; Yuan F
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1121-1124. PubMed ID: 30370510
[TBL] [Abstract][Full Text] [Related]
11. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
[TBL] [Abstract][Full Text] [Related]
12. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
13. Tumor regression grade in gastric cancer: Predictors and impact on outcome.
Blackham AU; Greenleaf E; Yamamoto M; Hollenbeak C; Gusani N; Coppola D; Pimiento JM; Wong J
J Surg Oncol; 2016 Sep; 114(4):434-9. PubMed ID: 27199217
[TBL] [Abstract][Full Text] [Related]
14. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
[TBL] [Abstract][Full Text] [Related]
15. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
[TBL] [Abstract][Full Text] [Related]
16. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
17. Optimal management of resectable gastric adenocarcinoma.
Buscariollo DL; Mamon HJ
Expert Rev Anticancer Ther; 2015; 15(8):931-41. PubMed ID: 26165449
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
Wang LB; Teng RY; Jiang ZN; Hu WX; Dong MJ; Yuan XM; Chen WJ; Jin M; Shen JG
J Surg Oncol; 2012 Mar; 105(3):293-6. PubMed ID: 21882201
[TBL] [Abstract][Full Text] [Related]
19. Tumor Regression Grade in Gastric Cancer After Preoperative Therapy.
Ikoma N; Estrella JS; Blum Murphy M; Das P; Minsky BD; Mansfield P; Ajani JA; Badgwell BD
J Gastrointest Surg; 2021 Jun; 25(6):1380-1387. PubMed ID: 32542556
[TBL] [Abstract][Full Text] [Related]
20. Response to Neoadjuvant Treatment Is Influenced by Grade in Gastric Cancer.
Kwong MLM; Denham L; Selleck MJ; Kim C; Kunihira K; Kubba R; Rojas R; Garberoglio C; Senthil M
Am Surg; 2019 Dec; 85(12):1419-1422. PubMed ID: 31908230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
